1 min read
Tempus AI Announces $200 Million AstraZeneca Oncology Renewal
The five-year payment commitment is tied to renewal of the companies’ existing oncology collaboration.

Tempus AI announced Nov. 18 that AstraZeneca had committed to pay it $200 million over five years after renewing the companies’ existing oncology collaboration.